Companies category powered by

Remedica signs MoU with Saudi AJA Pharma

Remedica has signed a non-binding memorandum of understanding (MoU) with AJA Pharma, a subsidiary of Saudi Chemical Company Holding (SCCH), marking the beginning of a strategic collaboration.

As part of this partnership, Cypriot pharmaceutical company Remedica and AJA Pharma will join forces to develop medicines and transfer technology, combining the strengths of the two companies to drive innovation and enter new markets.

MixCollage-14-Nov-2024-02-50-PM-19

“The Saudi market is not only pivotal in the Middle East, but also increasingly influential on the global stage,” Vijay Zutshi, Chief Commercial & Strategy Officer at Remedica said, adding: “Its rapid growth, strategic geographic position, and ambitious Vision 2030 reform plan make it a key player in shaping future economic trends and driving innovation across the healthcare industry. We are excited about our partnership with AJA Pharma that reinforces our shared mission to deliver innovative and high-quality pharmaceutical solutions and expands our reach to patient needs across key disease areas like Oncology, Cardiovascular, and Diabetes, in both tablets and injectables.”

Read More

17th IN Business Awards: Have you voted yet?
GOLD New Issue: Casting an Eye on AI
Hermes Airports issues reminder for parking arrangements at Larnaka Airport
Minthis Music Festival taking place on 9-13 July
US Ambassador meets with the President of the Cyprus Olympic Committee at the Olympic House
Second-placed Cyprus among the EU members transporting most freight by sea in 2023
The profiles, HQs, assets under management and more of Plug and Play Tech Center and Tenstorrent
Limassol Greens' plans to manage water and protect the environment
Shell Cyprus is giving three lucky winners the chance to visit Monza & watch the Formula 1 Grand Prix
Punin Group launches delicious new venture: The Croissant by Punin